Dr Bei Fang Liu, MD, PHD | |
5400 Mackinaw Rd, Suite 4200, Saginaw, MI 48604-9515 | |
(989) 791-2330 | |
(989) 791-2329 |
Full Name | Dr Bei Fang Liu |
---|---|
Gender | Female |
Speciality | Hematology/oncology |
Experience | 24 Years |
Location | 5400 Mackinaw Rd, Saginaw, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508887829 | NPI | - | NPPES |
183108305 | Medicaid | TX | |
183108302 | Medicaid | TX | |
183108304 | Medicaid | TX | |
8W0437 | Other | TX | BCTX |
183108303 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | 4301091752 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Covenant Medical Center | Saginaw, MI | Hospital |
Ascension St Mary's Hospital | Saginaw, MI | Hospital |
Tawas St Joseph Hospital | Tawas city, MI | Hospital |
Midmichigan Medical Center-west Branch | West branch, MI | Hospital |
Marlette Regional Hospital | Marlette, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Oncology Hematology Associates Of Saginaw Valley, P.c. | 1355328550 | 5 |
News Archive
GE Healthcare today introduced MR-Touch, a visual palpation technology that uses low frequency sound waves in combination with MRI to measure tissue elasticity. For centuries, clinicians have evaluated tissue stiffness—the physical property of tissue most affected by disease—through palpation. Based on technology invented at Mayo Clinic (Rochester, MN) and licensed to GE Healthcare,
Several studies have looked at possible links between maternal obesity during pregnancy and the risk of developmental disorders in the child. However, paternal obesity could be a greater risk factor than maternal obesity, according to a new study from the Norwegian Institute of Public Health.
When bacteria wage a turf war, some of the combatants have an extra weapon. Certain strains of the bacteria E. coli produce proteins that kill competing E. coli and other like microbes, and researchers from Newcastle University in England have recently discovered something surprising about one of these lethal proteins: even after the toxic folded portion of the protein is removed, the unfolded end is still deadly.
AVEO Oncology today announced that AVEO and Astellas Pharma Inc. have jointly decided to discontinue the BATON (Biomarker Assessment of Tivozanib in ONcology) breast cancer clinical trial, a Phase 2 study in patients with locally recurrent or metastatic triple negative breast cancer (TNBC), due to insufficient enrollment.
Neurodegenerative diseases like multiple sclerosis affect millions of people worldwide and occur when parts of the nervous system lose function over time.
› Verified 1 days ago
Entity Name | Oncology Hematology Associates Of Saginaw Valley, P.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366472169 PECOS PAC ID: 1355328550 Enrollment ID: O20040706001033 |
News Archive
GE Healthcare today introduced MR-Touch, a visual palpation technology that uses low frequency sound waves in combination with MRI to measure tissue elasticity. For centuries, clinicians have evaluated tissue stiffness—the physical property of tissue most affected by disease—through palpation. Based on technology invented at Mayo Clinic (Rochester, MN) and licensed to GE Healthcare,
Several studies have looked at possible links between maternal obesity during pregnancy and the risk of developmental disorders in the child. However, paternal obesity could be a greater risk factor than maternal obesity, according to a new study from the Norwegian Institute of Public Health.
When bacteria wage a turf war, some of the combatants have an extra weapon. Certain strains of the bacteria E. coli produce proteins that kill competing E. coli and other like microbes, and researchers from Newcastle University in England have recently discovered something surprising about one of these lethal proteins: even after the toxic folded portion of the protein is removed, the unfolded end is still deadly.
AVEO Oncology today announced that AVEO and Astellas Pharma Inc. have jointly decided to discontinue the BATON (Biomarker Assessment of Tivozanib in ONcology) breast cancer clinical trial, a Phase 2 study in patients with locally recurrent or metastatic triple negative breast cancer (TNBC), due to insufficient enrollment.
Neurodegenerative diseases like multiple sclerosis affect millions of people worldwide and occur when parts of the nervous system lose function over time.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Bei Fang Liu, MD, PHD 5400 Mackinaw Rd, Suite 4200, Saginaw, MI 48604-9515 Ph: (989) 791-2330 | Dr Bei Fang Liu, MD, PHD 5400 Mackinaw Rd, Suite 4200, Saginaw, MI 48604-9515 Ph: (989) 791-2330 |
News Archive
GE Healthcare today introduced MR-Touch, a visual palpation technology that uses low frequency sound waves in combination with MRI to measure tissue elasticity. For centuries, clinicians have evaluated tissue stiffness—the physical property of tissue most affected by disease—through palpation. Based on technology invented at Mayo Clinic (Rochester, MN) and licensed to GE Healthcare,
Several studies have looked at possible links between maternal obesity during pregnancy and the risk of developmental disorders in the child. However, paternal obesity could be a greater risk factor than maternal obesity, according to a new study from the Norwegian Institute of Public Health.
When bacteria wage a turf war, some of the combatants have an extra weapon. Certain strains of the bacteria E. coli produce proteins that kill competing E. coli and other like microbes, and researchers from Newcastle University in England have recently discovered something surprising about one of these lethal proteins: even after the toxic folded portion of the protein is removed, the unfolded end is still deadly.
AVEO Oncology today announced that AVEO and Astellas Pharma Inc. have jointly decided to discontinue the BATON (Biomarker Assessment of Tivozanib in ONcology) breast cancer clinical trial, a Phase 2 study in patients with locally recurrent or metastatic triple negative breast cancer (TNBC), due to insufficient enrollment.
Neurodegenerative diseases like multiple sclerosis affect millions of people worldwide and occur when parts of the nervous system lose function over time.
› Verified 1 days ago
Jerry Xavier, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1000 Houghton Ave, 1100 Internal Medicine, Saginaw, MI 48602 Phone: 989-583-5826 | |
Ray Peter Mangulabnan, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 3170 Hallmark Ct, Saginaw, MI 48603 Phone: 989-790-1275 Fax: 989-249-4199 | |
Shafia Beg, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-583-6800 | |
Dr. Natasa Petreska, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-746-7500 | |
Dr. Manoj Sharma, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4884 Berl Dr, Saginaw, MI 48604 Phone: 989-497-9395 Fax: 989-497-9599 | |
Minoo Khetarpal, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1320 N Michigan Ave, Suite 4, Saginaw, MI 48602 Phone: 989-755-5500 Fax: 989-755-7860 | |
Christine I Rohr, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-583-6800 Fax: 989-583-6915 |